{"id":"NCT02355665","sponsor":"McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.","briefTitle":"Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy","officialTitle":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study Using a Naturalistic Clinical Model to Measure the Efficacy and Safety of a Novel Nicotine Replacement Therapy in Smokers Motivated to Quit","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-01-31","primaryCompletion":"2015-09-30","completion":"2016-02-10","firstPosted":"2015-02-04","resultsPosted":"2019-01-08","lastUpdate":"2019-01-08"},"enrollment":1198,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Tobacco Dependence"],"interventions":[{"type":"DRUG","name":"Nicotine Spray","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Nicotine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy and safety of a novel nicotine product for continuous abstinence from smoking. Efficacy of product will be evaluated by assessments of self-reported abstinence, verified by exhaled carbon monoxide (CO) levels.","primaryOutcome":{"measure":"Percentage of Participants With Continuous Smoking Abstinence From Week 2 to Week 6","timeFrame":"Week 2 to Week 6","effectByArm":[{"arm":"Placebo","deltaMin":2.5,"sd":null},{"arm":"Nicotine","deltaMin":5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.021"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":8,"countries":["United States"]},"refs":{"pmids":["30452732"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":601},"commonTop":["Hiccups","Headache","Nausea","Upper Respiratory Tract Infection","Nasopharyngitis"]}}